Department of Pulmonary Vascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Cardiovascular Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Cardiology. 2023;148(2):161-172. doi: 10.1159/000530206. Epub 2023 Mar 23.
Pulmonary hypertension due to left heart failure (PH-LHF) is a disease with high prevalence and 3-year mortality rates. Consequently, timely identification of patients with high mortality risk is critical. This study aimed to build a nomogram for predicting 3-year mortality and screening high-risk PH-LHF patients.
This nomogram was developed on a training cohort of 175 patients with PH-LHF diagnosed by right heart catheterization. Multivariate Cox regression was used to identify independent predictors and develop this nomogram. The median total points obtained from the nomogram were used as a cutoff point, and patients were classified into low- and high-risk groups. The concordance index (C-index) and calibration curve were utilized to ascertain the predictive accuracy and discriminative ability of the nomogram. External validation was performed using a validation cohort of 77 PH-LHF patients from other centers.
Multivariate Cox regression showed that the New York Heart Association Functional classification (NYHA FC), uric acid level, and mean pulmonary arterial pressure were all independent predictors and incorporated into the nomogram. The nomogram showed good discrimination (C-index of 0.756; 95% CI: 0.688-0.854) and good calibration. The Kaplan-Meier survival analysis showed that patients in the high-risk group had worse survival (p < 0.001). In the external validation, the nomogram showed both good discrimination (C-index of 0.738; 95% CI: 0.591-0.846) and calibration.
The nomogram had a good performance in predicting 3-year mortality and can effectively identify high-risk patients. The nomogram may help to reduce the mortality of PH-LHF.
左心衰竭相关肺动脉高压(PH-LHF)是一种发病率高、3 年死亡率高的疾病。因此,及时识别高死亡率风险的患者至关重要。本研究旨在建立预测 3 年死亡率和筛选高危 PH-LHF 患者的列线图。
该列线图是基于 175 例经右心导管检查诊断为 PH-LHF 的患者的训练队列开发的。多变量 Cox 回归用于识别独立预测因素并开发该列线图。从列线图中获得的中位数总分作为截断点,并将患者分为低危和高危组。采用一致性指数(C 指数)和校准曲线来确定列线图的预测准确性和区分能力。使用来自其他中心的 77 例 PH-LHF 患者的验证队列进行外部验证。
多变量 Cox 回归显示,纽约心脏协会功能分级(NYHA FC)、尿酸水平和平均肺动脉压均为独立预测因素,并纳入列线图。该列线图具有良好的区分度(C 指数为 0.756;95%CI:0.688-0.854)和良好的校准度。Kaplan-Meier 生存分析显示,高危组患者的生存情况较差(p < 0.001)。在外部验证中,该列线图具有良好的区分度(C 指数为 0.738;95%CI:0.591-0.846)和校准度。
该列线图在预测 3 年死亡率方面表现良好,能够有效识别高危患者。该列线图可能有助于降低 PH-LHF 的死亡率。